GRANOT, Israel, March 20, 2013 (GLOBE NEWSWIRE) -- D. Medical Industries Ltd. (OTCBB:DMEDF) (TASE:DMED) (" D. Medical" or the " Company"), announced today that its Board of Directors approved the filing of a Form 15F with the Securities and Exchange Commission (" SEC") to voluntarily deregister its ordinary shares under the Securities Exchange Act of 1934 (the " Exchange Act"). The Company intends to file the Form 15F on or about March 29, 2013. The Company's reporting obligations under the Exchange Act will be suspended immediately upon the filing of Form 15F and will terminate 90 days thereafter if there are no objections from the SEC. The Company reserves the right to delay or withdraw the filing for any reason prior to their effectiveness.
- low U.S. trading volume;
- high public company costs in the U.S., including those associated with preparation and filing of the Company's periodic reports with the SEC;
- significant management time spent on U.S. regulatory compliance; and
- the potential impact of deregistration on Company shareholders resident in the U.S.
CONTACT: Company Contact: Orly Benizri Solomon Chief Executive Officer D. Medical Industries Ltd. T: +972-70-2508715 firstname.lastname@example.org